Gibco CTS OpTmizer T Cell Expansion Serum Free Medium, bag format, Model Numbers A1048503 and A10...
FDA Device Recall #Z-2542-2018 — Class II — May 10, 2018
Recall Summary
| Recall Number | Z-2542-2018 |
| Classification | Class II — Moderate risk |
| Date Initiated | May 10, 2018 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Life Technologies, Corp. |
| Location | Grand Island, NY |
| Product Type | Devices |
| Quantity | Updated as of 6/21/19: 6304 units |
Product Description
Gibco CTS OpTmizer T Cell Expansion Serum Free Medium, bag format, Model Numbers A1048503 and A1022103. Tissue and cell culture medium.
Reason for Recall
It has been determined that the fill port tube seal integrity was compromised during the manufacture of the product lot. This may cause media to leak out of the primary sterile packaging into outer non-sterile dust cover packaging, and subsequently mold may grow in the pooled, leaked media.
Distribution Pattern
Worldwide distribution. US states: CA, CO, CT, FL, GA, MA, MD, PA, RI, UT, and WA., Canada, France, Great Britain, Japan, Korea, Netherlands, and Switzerland.
Lot / Code Information
Lot: 1921298, 1921302 Updated as of 6/14/19: 1902977 1902981 1904379 1904381 1912383 1915452 1921291 1925754 1921291 1921298 1921302 1925754
Other Recalls from Life Technologies, Corp.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-0171-2019 | Class II | Gibco MEM Non-Essential Amino Acids Solution (1... | Aug 24, 2018 |
| Z-0174-2019 | Class II | Gibco GlutaMAX Supplement, for In-Vitro Diagnos... | Aug 24, 2018 |
| Z-0172-2019 | Class II | Gibco DPBS, calcium, magnesium, for In-Vitro Di... | Aug 24, 2018 |
| Z-0173-2019 | Class II | Gibco Sodium Pyruvate (100 mM) SKU 11360070, f... | Aug 24, 2018 |
| Z-2543-2018 | Class II | GIBCO CTS AIM V Serum-Free Media (SFM), Model N... | May 10, 2018 |
Frequently Asked Questions
Sterility recalls for medical devices vary in severity. If you have already had a procedure using a potentially non-sterile device, contact your healthcare provider immediately — you may need monitoring for signs of infection. Symptoms to watch for include fever, redness or swelling at the surgical site, unusual pain, or discharge. For devices that have not yet been used, they should be quarantined and returned to the manufacturer per the recall notice. Non-sterile implants can cause serious infections; early detection and treatment are critical.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.